Bank Of America Corp Edwards Lifesciences Corp Call Options Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $214,920 - $337,608	3,600 Added 54.55%	10,200 $673,000
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $5.02 Million - $5.61 Million	-59,500 Reduced 90.02%	6,600 $609,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $6.45 Million - $8.5 Million	-88,900 Reduced 57.35%	66,100 $6.32 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $9.57 Million - $12.1 Million	155,000 New	155,000 $11.8 Million
Q4 2021 Feb 08, 2022	SELL	$106.37 - $130.68 $7.09 Million - $8.72 Million	-66,700 Reduced 90.5%	7,000 $907,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $3.22 Million - $3.84 Million	-31,300 Reduced 29.81%	73,700 $8.34 Million
Q2 2021 Sep 13, 2021	BUY	$83.84 - $104.76 $8.8 Million - $11 Million	105,000 New	105,000 $10.9 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.